参考文献/References:
[1]赵雪千,王雯瑾,张楠辉,等.IgA肾病患者补体血清水平及其系膜沉积强度与肾病理损伤程度的相关性[J].陕西医学杂志,2025,54(4):555-559.
[2]SUN Q,XIE L,SONG J,et al.Evodiamine:A review of its pharmacology,toxicity,pharmacokinetics and preparation researches[J].J Ethnopharmacol,2020,262:113164.
[3]YE C,ZHANG N,ZHAO Q,et al.Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway[J].Phytother Res,2021,35(6):3406-3417.
[4]YU Y,HUANG X,LIANG C,et al.Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer[J].Eur J Pharmacol,2023,957:176007.
[5]PENG F,WU L,WU J,et al.Serum levels of sonic hedgehog in patients with IgA nephropathy are closely associated with intrarenal arteriolar lesions[J].Clin Biochem,2024,123(1):110-121.
[6]LUO Y,JIANG J,CHENG J,et al.Inhibitory effects of rhein on renal interstitial fibrosis via the SHH-Gli1 signal pathway[J].Evid Based Complement Alternat Med,2022,20(4):43-55.
[7]LI J J,LI L,LI S,et al.Sinomenine hydrochloride protects IgA nephropathy through regulating cell growth and apoptosis of T and B lymphocytes[J].Drug Des Devel Ther,2024,18(4):1247-1262.
[8]LI Y,LI W,JIANG H.Vitamin D and hydroxychloroquine reduce renal injury and Ki67 expression in a rat model of IgA nephropathy via TLR4[J].Chin Med J (Engl),2021,134(23):2896-2898.
[9]史慧远,宋纯东,宋珂,等.基于NIK/IKKα/p52通路探讨雷公藤多苷对IgA肾病大鼠的肾脏保护作用机制[J].中医学报,2024,39(8):1754-1760.
[10]PEREGUD D I,SHIROBOKOVA N I,KVICHANSKY A A,et al.Purmorphamine alters anxiety-like behavior and expression of hedgehog cascade components in rat brain after alcohol withdrawal[J].Biochemistry (Mosc),2024,89(11):1938-1949.
[11]SCIONTI K,MOLYNEUX K,SELVASKANDAN H,et al.New insights into the pathogenesis and treatment strategies in IgA nephropathy[J].Glomerular Dis,2021,2(1):15-29.
[12]ROBERTS L E,WILLIAMS C E C,ONI L,et al.IgA nephropathy:Emerging mechanisms of disease[J].Indian J Nephrol,2024,34(4):297-309.
[13]NORREGAARD R,MUTSAERS H A M,FROKI R J,et al.Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis[J].Physiol Rev,2023,103(4):2827-2872.
[14]HADPECH S,THONGBOONKERD V.Epithelial-mesenchymal plasticity in kidney fibrosis[J].Genesis,2024,62(1):e23529.
[15]LI L,FU H,LIU Y.The fibrogenic niche in kidney fibrosis:Components and mechanisms[J].Nat Rev Nephrol,2022,18(9):545-557.
[16]ERASLAN E,TANYELI A,POLAT E,et al.Evodiamine alleviates kidney ischemia reperfusion injury in rats:A biochemical and histopathological study[J].J Cell Biochem,2020,120(10):17159-17166.
[17]邹鑫,于冰,徐龙辉,等.吴茱萸碱调节SphK1/S1P信号通路对慢性肾衰竭大鼠肾纤维化的影响[J].广州中医药大学学报,2024,41(6):1560-1566.
[18]LU X,ZHANG W,LIU Y,et al.Evodiamine exerts inhibitory roles in nonsmall cell lung cancer cell A549 and its subpopulation of stemlike cells[J].Exp Ther Med,2022,24(6):74-86.
[19]张锦华,高明,朱小静,等.促红细胞生成素对高糖诱导大鼠近端肾小管上皮细胞转分化的影响[J].陕西医学杂志,2022,51(10):1183-1186,1200.
[20]ZENG J,BAO X.Tanshinone ⅡA attenuates high glucose-induced epithelial-to-mesenchymal transition in HK-2 cells through VDR/Wnt/β-catenin signaling pathway[J].Folia Histochem Cytobiol,2021,59(4):259-270.
[21]SIGAFOOS A N,PARADISE B D,FERNANDEZ-ZAPICO M E.Hedgehog/GLI signaling pathway:Transduction,regulation,and implications for disease[J].Cancers (Basel),2021,13(14):34-45.
[22]WANG C,LAI Z,TAN H,et al.Impaired cardiomyocytes accelerate cardiac hypertrophy and fibrosis by delivering exosomes containing Shh/N-Shh/Gli1 in angiotensin Ⅱ infused mice[J].Heliyon,2024,10(20):39332.
[23]WANG D,YIN L,CHEN R,et al.Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease[J].Front Med (Lausanne),2023,9(4):101-120.
[24]LI Y,TU H,LUO Y,et al.Shen-shuai-ling formulation attenuates renal interstitial fibrosis in chronic kidney disease by regulating SHH-Gli1 signaling pathway[J].Evid Based Complement Alternat Med,2022,20(2):37-45.
[25]LUO Y,JIANG J,CHENG J,et al.Inhibitory effects of rhein on renal interstitial fibrosis via the SHH-Gli1 signal pathway[J].Evid Based Complement Alternat Med,2022,20(5):4398-4409.